DISTRIBUTORS: WEBINAR February  9th 4:30 PM EST FOR NEW FDA CLEARED Point-of-Care MicroFat Tissue Processing

DISTRIBUTORS: WEBINAR February 9th 4:30 PM EST FOR NEW FDA CLEARED Point-of-Care MicroFat Tissue Processing

WEBINAR Tuesday February 9th at 4:30 PM EST FOR NEW FDA CLEARED for Point-of-Care Fat Tissue Processing for a Broad Range of Applications

Attention Distributors and Reps: I am setting up a webinar on Tuesday February 9th at 4:30 PM EST to introduce the launch of the new Jointech MiniTC tissue processing device for Cell Enriched Microfat. We are currently looking for Distributors and Reps to market this new technology and have already recruited Key Opinion Leaders and Spokespersons for the Company.

MiniTCTM is FDA cleared sterile closed-loop disposable medical device for processing of lipoaspirate (fat). The final product of the processing is a fi ne washed fractured fat tissue known as micronized fat or nanofat. It’s intended for autologous multi-functional implant alone or in conjunction with other biocompatible carriers. The device can be used in a broad range of therapeutic areas, such as facial aesthetics, plastic corrective surgeries, orthopedics and wound care. As a closed-loop device, MiniTC (MTC) allows for processing of lipoaspirate of adipose tissue without exposure to the external environment in virtually any type of clinical setting. When implanted by injection, the essential eff ect can be attributed to the preservation of the integrity of adipose tissue lobules and the stromal cells within its natural niche. Together it constitutes structural and trophic factors that trigger the reconstruction, regeneration and healing of connective tissues, which is well recognized in the fi eld of musculoskeletal disorders. 

MiniTC is a disposable, closed loop medical device that can be used in the clinic setting, with no change in infrastructure, eliminating the need for manual processing of fat tissue in the lab. Also, the device is less costly, cumbersome and labor intensive compared to what currently exists. MiniTC’s performance has been validated in vitro and in vivo, including an observational orthopedic study in Israel and the UAE, involving 47 patients – with 92% reporting functional improvement and no complications. Additionally, it was validated in clinical studies with lymphoedema patients as well as in the areas of facial aesthetics, hair regrowth and wound care.

“Jointechlabs’ MiniTC device is easy to use and effective,” said Joseph Purita, M.D., orthopedic surgeon and director of the Institute of Regenerative Medicine in Boca Raton, Florida. “It is encouraging to see the continuing development of new technology for regenerative medicine that is compliant with FDA guidelines."

Microfat Isolation

MiniTC allows for processing of of adipose (fat) tissue without exposure to the external environment. The final product of the processing is a fine washed fractured fat tissue known as fat graft or microfat. When implanted by injection, the essential effect can be attributed to the preservation of the integrity of fat tissue and the stromal cells within its natural niche. Together it constitutes structural factors that trigger the reconstruction, regeneration and healing of connective tissues. It’s a gentle process that uses an individual’s own fat tissue to cushion and support areas of injury or damage as the body heals itself.

This is a great opportunity for anyone interested in the latest in Human Biologics. Please do not hesitate to reach out to me with any questions, comments or feedback regarding the device or the business opportunity, just inbox me

This Webinar will be handled as a ZOOM call and here is how you can participate:

When: Tuesday, February 9th at 4:30 PM EST

Join Zoom Meeting

Topic: MiniTC launching introduction

Time: Feb 9, 2021 4:30 PM EST, 3:30 PM Central Time (US and Canada)

Join Zoom Meeting

https://us02web.zoom.us/j/3246924445

Meeting ID: 324 692 4445

One tap mobile

+13126266799,,3246924445# US (Chicago)

+16465588656,,3246924445# US (New York)


Thank you and I look forward to your participation

Sincerely,

Jonathan Schwartz

President, Jointech Labs Inc

President, CEO, MedicalMarvels LLC

tel. 201-218-9743

SKYPE # medicalmarvels

Jonathan Schwartz

CEO at MEDICALMARVELS LLC

4 年

Thank you to all who participated in this ZOOM WEBINAR. I will be hosting another one in a couple of weeks- stay tuned. Anyone else who is interested in the interim can inbox me for more information on this opportunity.

回复
dirk de schaepmeester

Platelet-rich plasma - Bone Marrow Aspiration Concentration - Stromal Vascular Fractions

4 年

A device for Europe ? Looking for a distributor ?

回复

要查看或添加评论,请登录

Jonathan Schwartz的更多文章

社区洞察

其他会员也浏览了